Authors: Hatzakis, A Gargalianos, P Kiosses, V Lazanas, M Sypsa, V Anastassopoulou, C Vigklis, V Sambatakou, H Botsi, C Paraskevis, D Stalgis, C

Citation: A. Hatzakis et al., Low-dose IFN-alpha monotherapy in treatment-naive individuals with HIV-1 infection: Evidence of potent suppression of viral replication, J INTERF CY, 21(10), 2001, pp. 861-869

Authors: Anastassopoulou, CG Toulomi, G Katsoulidou, A Hatzitheodorou, H Pappa, M Paraskevis, D Lazanas, M Gargalianos, P Hatzakis, A

Citation: Cg. Anastassopoulou et al., Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma, J VIROL MET, 91(1), 2001, pp. 67-74

Authors: Paraskevis, D Magiorkinis, E Magiorkinis, G Anastassopoulou, C Lazanas, M Chrysos, G Vandamme, AM Hatzakis, A

Citation: D. Paraskevis et al., Molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): evidence to support the existence of a novel HIV-1 subtype, J GEN VIROL, 82, 2001, pp. 2509-2514

Authors: Magiorkinis, E Paraskevis, D Lazanas, M Kiosses, VG Gargalianos, P Hatzakis, A

Citation: E. Magiorkinis et al., Identification of reverse transcriptase mutations associated with HIV-1 drug resistance mainly against non-nucleoside reverse transcriptase inhibitors in treatment-naive patients, AIDS, 13(10), 1999, pp. 1276-1278